Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection81

Select a period of time:

Views

Views
November 20256
December 20254
January 20267
February 20260
March 20266
April 20265
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Finland5
United Kingdom3
Brazil3
Mexico2
Ecuador2
Austria1
Chile1
Colombia1
Kenya1
 

Top cities views

Views
Helsinki5
Araruama1
Ashburn1
Asunción1
Buenaventura1
Cuenca1
Guayaquil1
Iztacalco1
Morecambe1
Nairobi1